(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) fell by a staggering 24.4% in 14 days from $22.34 to $16.89 at 15:01 EST on Tuesday, after three successive sessions in a row of losses. NASDAQ is rising 0.34% to $10,846.33, after four consecutive sessions in a row of losses.
Castle Biosciences’s last close was $18.09, 77.08% below its 52-week high of $78.92.
Today’s last reported volume for Castle Biosciences is 97817 which is 73.13% below its average volume of 364090.
The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.
Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.16%, a positive 0.08%, and a positive 5.32%, respectively.
Castle Biosciences’s highest amplitude of average volatility was 5.50% (last week), 5.11% (last month), and 5.32% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be overbought (>=80).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $16.89 at 15:01 EST, under its 52-week low of $17.01.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way under its 50-day moving average of $24.61 and way under its 200-day moving average of $44.68.
More news about Castle Biosciences (CSTL).